ImportRefusal LogoImportRefusal

Olon SpA

⚠️ High Risk

FEI: 3002808159 • Casaletto Lodigiano, Lodi • ITALY

FEI

FEI Number

3002808159

📍

Location

Casaletto Lodigiano, Lodi

🇮🇹

Country

ITALY
🏢

Address

Via Livelli 1, Frazione Mairano, Casaletto Lodigiano, Lodi, Italy

High Risk

FDA Import Risk Assessment

50.1
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

15
Total Refusals
6
Unique Violations
4/10/2023
Latest Refusal
6/25/2002
Earliest Refusal

Score Breakdown

Violation Severity
67.9×40%
Refusal Volume
44.6×30%
Recency
44.3×20%
Frequency
7.2×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1611×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

1183×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

752×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

22801×

DIRSEXMPT

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a drug within the meaning of Section 201(g) and it lacks adequate directions for use.

271×

DRUG GMPS

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the methods used in and controls used for the manufacture, processing, packing, or holding of drugs and other products do not appear to conform to current good manufacturing practices within the meaning of Section 501(a)(2)(B).

32801×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

Refusal History

DateProductViolationsDivision
4/10/2023
61WCS18MICONAZOLE NITRATE (ANTI-FUNGAL) (NOT ANTIBIOTIC)
2280DIRSEXMPT
Division of Northeast Imports (DNEI)
12/6/2017
61WCT04CLOTRIMAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC)
118NOT LISTED
3280FRNMFGREG
Division of Southwest Imports (DSWI)
7/21/2009
61KDS13CLIDINIUM BROMIDE (ANTI-CHOLINERGIC)
16DIRECTIONS
New York District Office (NYK-DO)
8/1/2008
63BCS26IPRATROPIUM BROMIDE (BRONCHODILATOR)
75UNAPPROVED
New Orleans District Office (NOL-DO)
2/21/2007
62OBY39LABETALOL HYDROCHLORIDE (ANTI-HYPERTENSIVE - PART II)
27DRUG GMPS
75UNAPPROVED
New Orleans District Office (NOL-DO)
12/21/2004
62KCS08LOPERAMIDE HYDROCHLORIDE (ANTI-PERISTALTIC, ANTI-DIARRHEAL)
16DIRECTIONS
New York District Office (NYK-DO)
4/23/2003
61NCS44NORTRIPTYLINE HCL (ANTI-DEPRESSANT)
16DIRECTIONS
New York District Office (NYK-DO)
1/22/2003
61NCS03AMITRIPTYLINE HCL (ANTI-DEPRESSANT)
16DIRECTIONS
New York District Office (NYK-DO)
1/22/2003
64BCS41TRICHLORMETHIAZIDE (DIURETIC)
16DIRECTIONS
New York District Office (NYK-DO)
12/31/2002
61NCS05BUPROPION HCL (ANTI-DEPRESSANT)
16DIRECTIONS
New York District Office (NYK-DO)
12/31/2002
65QCS60CYCLOBENZAPRINE HYDROCHLORIDE (RELAXANT)
16DIRECTIONS
New York District Office (NYK-DO)
7/25/2002
61WCZ04CLOTRIMAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC)
118NOT LISTED
16DIRECTIONS
New York District Office (NYK-DO)
7/25/2002
61WCZ04CLOTRIMAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC)
118NOT LISTED
16DIRECTIONS
New York District Office (NYK-DO)
6/25/2002
61NCS03AMITRIPTYLINE HCL (ANTI-DEPRESSANT)
16DIRECTIONS
New York District Office (NYK-DO)
6/25/2002
61NCS03AMITRIPTYLINE HCL (ANTI-DEPRESSANT)
16DIRECTIONS
New York District Office (NYK-DO)

Frequently Asked Questions

What is Olon SpA's FDA import refusal history?

Olon SpA (FEI: 3002808159) has 15 FDA import refusal record(s) in our database, spanning from 6/25/2002 to 4/10/2023.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Olon SpA's FEI number is 3002808159.

What types of violations has Olon SpA received?

Olon SpA has been cited for 6 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Olon SpA come from?

All FDA import refusal data for Olon SpA is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.